Skip to content
10-Q

Quarterly Report

ALEXION PHARMACEUTICALS, INC.

0000899866-20-000088

← back to feed
Filed
Oct 29, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 27, 2020 218.85M sh
Shares Diluted Q3 2020 · Sep 30, 2020 220.6M sh
Shares Diluted Q3 2020 · Sep 30, 2020 221.9M sh
Shares Diluted Q3 2020 · Sep 30, 2019 224.5M sh
Shares Diluted Q3 2020 · Sep 30, 2019 225.4M sh
Stock Repurchased Q3 2020 · Sep 30, 2020 $434.3M
Stock Repurchased Q3 2020 · Sep 30, 2019 $383.5M
Capex Q3 2020 · Sep 30, 2020 $29.2M
Capex Q3 2020 · Sep 30, 2019 $124.7M
Operating Cash Flow Q3 2020 · Sep 30, 2020 $2.16B
Operating Cash Flow Q3 2020 · Sep 30, 2019 $1.57B
Long Term Debt Q3 2020 · Sep 30, 2020 $2.45B
Long Term Debt Q3 2020 · Dec 31, 2019 $2.38B
Short Term Debt Q3 2020 · Sep 30, 2020 $138.6M
Short Term Debt Q3 2020 · Dec 31, 2019 $126.7M
Cash And Equivalents Q3 2020 · Sep 30, 2020 $2.27B
Cash And Equivalents Q3 2020 · Dec 31, 2019 $2.69B
Cash And Equivalents Q3 2020 · Sep 30, 2019 $2.17B
Stockholders Equity Q3 2020 · Sep 30, 2020 $11.07B
Stockholders Equity Q3 2020 · Jun 30, 2020 $10.49B
Stockholders Equity Q3 2020 · Dec 31, 2019 $11.27B
Stockholders Equity Q3 2020 · Sep 30, 2019 $10.37B
Stockholders Equity Q3 2020 · Jun 30, 2019 $10.16B
Stockholders Equity Q3 2020 · Dec 31, 2018 $9.17B
Current Liabilities Q3 2020 · Sep 30, 2020 $1.33B
Current Liabilities Q3 2020 · Dec 31, 2019 $1.19B
Total Liabilities Q3 2020 · Sep 30, 2020 $6.47B
Total Liabilities Q3 2020 · Dec 31, 2019 $6.27B
Current Assets Q3 2020 · Sep 30, 2020 $5.07B
Current Assets Q3 2020 · Dec 31, 2019 $5.08B
Total Assets Q3 2020 · Sep 30, 2020 $17.55B
Total Assets Q3 2020 · Dec 31, 2019 $17.54B
Eps Diluted Q3 2020 · Sep 30, 2020 $2.62
Eps Diluted Q3 2020 · Sep 30, 2020 $0.30
Eps Diluted Q3 2020 · Sep 30, 2019 $2.08
Eps Diluted Q3 2020 · Sep 30, 2019 $6.72
Eps Basic Q3 2020 · Sep 30, 2020 $2.64
Eps Basic Q3 2020 · Sep 30, 2020 $0.31
Eps Basic Q3 2020 · Sep 30, 2019 $2.09
Eps Basic Q3 2020 · Sep 30, 2019 $6.77
Sga Expense Q3 2020 · Sep 30, 2020 $334.2M
Sga Expense Q3 2020 · Sep 30, 2020 $955.5M
Sga Expense Q3 2020 · Sep 30, 2019 $299.3M
Sga Expense Q3 2020 · Sep 30, 2019 $880.1M
Net Income Q3 2020 · Sep 30, 2020 $578.1M
Net Income Q3 2020 · Sep 30, 2020 $67.6M
Net Income Q3 2020 · Sep 30, 2019 $467.6M
Net Income Q3 2020 · Sep 30, 2019 $1.52B
Operating Income Q3 2020 · Sep 30, 2020 $684.9M
Operating Income Q3 2020 · Sep 30, 2020 $10.2M
Operating Income Q3 2020 · Sep 30, 2019 $530M
Operating Income Q3 2020 · Sep 30, 2019 $1.58B
Revenue Q3 2020 · Sep 30, 2020 $1.59B
Revenue Q3 2020 · Sep 30, 2020 $4.48B
Revenue Q3 2020 · Sep 30, 2019 $1.26B
Revenue Q3 2020 · Sep 30, 2019 $3.61B